BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $17,958,000 | +4.9% | 118,794 | +1.1% | 0.00% | 0.0% |
Q2 2022 | $17,122,000 | -90.7% | 117,508 | -92.4% | 0.00% | -86.7% |
Q1 2022 | $184,003,000 | -11.6% | 1,551,851 | +2.7% | 0.02% | 0.0% |
Q4 2021 | $208,210,000 | +17.0% | 1,510,850 | +17.9% | 0.02% | +7.1% |
Q3 2021 | $177,979,000 | +60.8% | 1,281,250 | +12.4% | 0.01% | +55.6% |
Q2 2021 | $110,688,000 | +44.8% | 1,140,174 | +2.0% | 0.01% | +28.6% |
Q1 2021 | $76,431,000 | -34.1% | 1,118,224 | -17.4% | 0.01% | -30.0% |
Q4 2020 | $116,063,000 | +29.4% | 1,354,137 | -1.9% | 0.01% | +11.1% |
Q3 2020 | $89,715,000 | -9.3% | 1,380,017 | +2.0% | 0.01% | -18.2% |
Q2 2020 | $98,875,000 | +267.6% | 1,352,414 | +71.1% | 0.01% | +175.0% |
Q1 2020 | $26,896,000 | -29.5% | 790,343 | +12.9% | 0.00% | 0.0% |
Q4 2019 | $38,124,000 | +30.5% | 700,279 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $29,216,000 | +96.6% | 700,279 | +106.4% | 0.00% | +100.0% |
Q2 2019 | $14,861,000 | -36.7% | 339,363 | -25.6% | 0.00% | -33.3% |
Q1 2019 | $23,489,000 | -24.5% | 456,367 | -45.8% | 0.00% | -25.0% |
Q4 2018 | $31,109,000 | -7.8% | 841,232 | -6.4% | 0.00% | 0.0% |
Q3 2018 | $33,751,000 | -36.9% | 898,832 | -33.6% | 0.00% | -33.3% |
Q2 2018 | $53,513,000 | +309.0% | 1,354,064 | +166.6% | 0.01% | +200.0% |
Q1 2018 | $13,084,000 | -53.2% | 507,923 | -51.0% | 0.00% | -33.3% |
Q4 2017 | $27,938,000 | -27.8% | 1,035,523 | 0.0% | 0.00% | -40.0% |
Q3 2017 | $38,708,000 | +49.5% | 1,035,523 | 0.0% | 0.01% | +66.7% |
Q2 2017 | $25,888,000 | – | 1,035,523 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |